Drug intelligence / Profile preview

Maroisin

Development stage: Unknown
Lead developer: Hankook Shinyak
Administration: Oral

Overview

**Maroisin** is an orally administered over-the-counter Korean herbal medicine marketed by Hankook Shinyak for localized purulent inflammatory conditions characterized by redness, swelling, induration, and pain. The 500 mg capsule is a multi-herb preparation containing immature bitter orange fruit, balloon flower root, white peony root, ginger rhizome, jujube fruit, and licorice root. Its molecular targets and a specific pharmacologic mechanism have not been established in the public product information. ([hsp.co.kr](https://www.hsp.co.kr/eng/product/view.html?code=0100&code2=0114&no=57))

Brand names: Hanshin Maroisin CapsuleMaroisinMaroisin Cap.Maroisin Capsule
Other names: 마로이신한신마로이신캡슐

Beyond the preview

Go deeper on Maroisin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Maroisin.

Explore the full profile